Pathological upgrading and upstaging of patients eligible for active surveillance according to currently used protocols

Int J Urol. 2014 Apr;21(4):377-81. doi: 10.1111/iju.12326. Epub 2013 Oct 29.

Abstract

Objectives: To investigate the ability of six contemporary active surveillance protocols to appropriately select active surveillance candidates among Korean men who underwent radical prostatectomy.

Methods: Between January 2001 and December 2011, 1968 patients underwent radical prostatectomy for prostate cancer at Samsung Medical Center, Seoul, Korea. Patients met the criteria for active surveillance according to six currently used criteria, including those from the Johns Hopkins Hospital, the University of Toronto, the University of California at San Francisco, the Prospective Prostate Cancer Research International Active Surveillance, the University of Miami and the Memorial Sloan-Kettering Cancer Center. The rates of Gleason score upgrading, upstaging and misclassification at final pathology were assessed.

Results: Among 1006 assessable patients, the percentage of men eligible for active surveillance varied from 13.5% to 38.5%, depending on the criteria used. The rates of upgrading ranged from 41.6% to 50.6%. Extracapsular extension was reported in 4.1% to 8.5% of patients, whereas seminal vesicle invasion was reported in 0.5% to 1.6% of patients. The upstaging rates according to the six active surveillance criteria varied from 4.5% to 9.3%, and the rates of misclassification varied from 44.5% to 54.8%.

Conclusions: Currently available active surveillance criteria might not be suitable in Korean patients with prostate cancer, as they have a high likelihood of underestimating cancer.

Keywords: active surveillance; clinical protocols; insignificant; prostate cancer; radical prostatectomy.

MeSH terms

  • Aged
  • Asian People
  • Humans
  • Male
  • Middle Aged
  • Neoadjuvant Therapy / methods
  • Neoplasm Grading
  • Population Surveillance / methods*
  • Prostate / pathology
  • Prostatectomy / methods*
  • Prostatic Neoplasms / drug therapy
  • Prostatic Neoplasms / pathology*
  • Prostatic Neoplasms / surgery*
  • Republic of Korea